Nano Cap Podcast

Will Tjernlund

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph. Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.

  1. 20h ago

    Alliance Advisors - Joe Caruso - Ep:084 - Nano Cap Podcast

    Will Tjernlund welcomes Joseph “Joe” Caruso, CEO and co-founder of Alliance Advisors, to the Nano Cap Podcast for a conversation about proxy voting, shareholder communications, and retail investor engagement. Caruso explains why nano-cap and micro-cap companies can struggle to reach their own shareholders, and how those barriers can affect critical votes, capital raises, and business growth. What is the difference between an objecting beneficial owner (OBO) and a non-objecting beneficial owner (NOBO)? Caruso breaks down these shareholder classifications in plain English and shares why he is advocating for changes that would give public companies more direct access to their investors. He also explains how a company can struggle to achieve a shareholder quorum even when investors might support its proposals. The conversation explores how shareholder engagement has evolved from mailed proxy statements and phone calls to text-to-vote campaigns, email outreach, and investor communities on Reddit and Stocktwits. For smaller public companies with limited budgets, reaching shareholders efficiently can make a meaningful difference. Topics include: How proxy solicitation and shareholder voting workOBO vs. NOBO classifications and shareholder transparencyWhy retail investors matter to nano-cap and micro-cap companiesHow voting participation can affect financing and share issuanceDigital communication tools for investor relationsCaruso’s case for reforming shareholder communication rulesListen for a behind-the-scenes look at corporate governance and the role individual investors play in the future of small public companies. Subscribe to the Nano Cap Podcast for more conversations with the people behind some of the smallest but mightiest publicly traded companies from around the world. Alliance Advisors: https://allianceadvisors.com/ Nano Cap Podcast: https://www.nanocappod.com/ DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions. Guests may have paid to be on the podcast.

  2. 2d ago

    Niki BioSolutions - $NIKI - Ep:083 - Nano Cap Podcast

    Could Alzheimer’s biomarkers help identify risk years before symptoms appear? Will Tjernlund interviews Dr. Alidad Mirskandari of Niki BioSolutions about Alzheimer’s blood test development, early detection, and the path from clinical research to commercially available diagnostics. Dr. Mirskandari shares his journey from biology and genetics to an MBA, consulting, Wall Street, and biotech leadership. He explains Niki BioSolutions’ strategy for pharmaceutical biomarker testing services and its work toward a clinical biomarker panel, subject to validation and clinical utility studies. In this episode, we discuss: How Alzheimer’s biomarkers may change five to twenty years before symptoms emerge.How pharma biomarker testing can support patient recruitment and clinical studies.What it takes to develop lab-developed tests, demonstrate clinical utility, and pursue insurance reimbursement.Why biotech commercialization needs to begin alongside product development.How earlier risk identification could inform monitoring, treatment discussions, and referrals to neurologists.Lessons from the dot-com crash and Dr. Mirskandari’s vision for Niki BioSolutions over the next five years.Listen for a look at the science, business, and reimbursement challenges shaping Alzheimer’s diagnostics and the future of early detection. Niki BioSolutions: https://www.nikibiosolutions.com/ Nano Cap Podcast: https://www.nanocappod.com/ DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

    Niki BioSolutions - $NIKI - Ep:083 - Nano Cap Podcast

Trailer

Ratings & Reviews

5
out of 5
6 Ratings

About

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph. Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.